DK464483D0 - Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel - Google Patents

Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel

Info

Publication number: DK464483D0
Authority: DK; Denmark
Prior art keywords: preparation; procedure; fibrinolytic agent; pharmaceutical preparation; pharmaceutical
Prior art date: 1982-10-08

Application number

DK4644/83A

Other languages

English (en)

Other versions

DK161564B (da

DK464483A (da

DK161564C (da

Inventor

Francesco Borrelli

Francesco Antonetti

Original Assignee

Serono Ist Farm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-10-08

Filing date

1983-10-07

Publication date

1983-10-07

1983-10-07 Application filed by Serono Ist Farm filed Critical Serono Ist Farm

1983-10-07 Publication of DK464483D0 publication Critical patent/DK464483D0/da

1984-04-09 Publication of DK464483A publication Critical patent/DK464483A/da

1991-07-22 Publication of DK161564B publication Critical patent/DK161564B/da

1992-01-06 Application granted granted Critical

1992-01-06 Publication of DK161564C publication Critical patent/DK161564C/da

Links

239000003527 fibrinolytic agent Substances 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
206010061216 Infarction Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000009792 diffusion process Methods 0.000 abstract 1
230000007574 infarction Effects 0.000 abstract 1
210000004165 myocardium Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)

DK464483A 1982-10-08 1983-10-07 Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase DK161564C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT49241/82A IT1189379B (it)	1982-10-08	1982-10-08	Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico
IT4924182		1982-10-08

Publications (4)

Publication Number	Publication Date
DK464483D0 true DK464483D0 (da)	1983-10-07
DK464483A DK464483A (da)	1984-04-09
DK161564B DK161564B (da)	1991-07-22
DK161564C DK161564C (da)	1992-01-06

Family

ID=11270058

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK464483A DK161564C (da)	1982-10-08	1983-10-07	Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase

Country Status (12)

Country	Link
US (1)	US4568543A (da)
EP (1)	EP0106812B1 (da)
JP (1)	JPS5989630A (da)
AT (1)	ATE44467T1 (da)
AU (1)	AU559192B2 (da)
CA (1)	CA1217717A (da)
DE (2)	DE106812T1 (da)
DK (1)	DK161564C (da)
ES (1)	ES8704736A1 (da)
IL (1)	IL69938A (da)
IT (1)	IT1189379B (da)
ZA (1)	ZA837484B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5275812A (en) *	1985-06-07	1994-01-04	The General Hospital Corporation	Method of treatment for myocardial infarction
US5279824A (en) *	1988-04-14	1994-01-18	Merck Patent Gmbh	Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
DE69019141T2 (de) *	1989-01-27	1996-01-18	Immunolytics Inc	Zusammensetzung und verfahren für die behandlung gutartiger prostata-hypertrophie.
CA2027936C (en)	1989-10-23	2001-07-24	Smithkline Beecham Corporation	Cyclic anti-aggregatory peptides
US5939412A (en) *	1992-06-26	1999-08-17	Smithkline Beecham Corporation	Bicyclic fibrinogen antagonists
JPH10511356A (ja) *	1994-12-22	1998-11-04	スミスクライン・ビーチャム・コーポレイション	フィブリノゲン受容体拮抗物質
EP1521523A4 (en) *	2002-05-20	2006-04-19	Univ Texas	METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS
US7220407B2 (en) *	2003-10-27	2007-05-22	Amgen Inc.	G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1179787A (en) *	1967-03-22	1970-01-28	Biorex Laboratories Ltd	Stabilised and Potentiated Therapeutic Enzyme Compositions
US3708575A (en) *	1970-05-13	1973-01-02	Biorex Laboratories Ltd	Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US4271150A (en) *	1979-03-07	1981-06-02	Zeria-Shinyaku Kogyo Kabushiki Kaisha	Urokinase preparation for oral administration

1982
- 1982-10-08 IT IT49241/82A patent/IT1189379B/it active
1983
- 1983-10-05 EP EP83830192A patent/EP0106812B1/en not_active Expired
- 1983-10-05 DE DE198383830192T patent/DE106812T1/de active Pending
- 1983-10-05 DE DE8383830192T patent/DE3380166D1/de not_active Expired
- 1983-10-05 AU AU19883/83A patent/AU559192B2/en not_active Expired
- 1983-10-05 AT AT83830192T patent/ATE44467T1/de not_active IP Right Cessation
- 1983-10-06 ES ES526300A patent/ES8704736A1/es not_active Expired
- 1983-10-06 ZA ZA837484A patent/ZA837484B/xx unknown
- 1983-10-07 CA CA000438588A patent/CA1217717A/en not_active Expired
- 1983-10-07 DK DK464483A patent/DK161564C/da not_active IP Right Cessation
- 1983-10-07 JP JP58187167A patent/JPS5989630A/ja active Granted
- 1983-10-09 IL IL69938A patent/IL69938A/xx not_active IP Right Cessation
1984
- 1984-11-08 US US06/669,462 patent/US4568543A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA1217717A (en)	1987-02-10
JPS6150927B2 (da)	1986-11-06
DE106812T1 (de)	1984-08-30
IT1189379B (it)	1988-02-04
ES526300A0 (es)	1987-05-01
ES8704736A1 (es)	1987-05-01
IL69938A0 (en)	1984-01-31
EP0106812B1 (en)	1989-07-12
AU1988383A (en)	1984-04-12
DK161564B (da)	1991-07-22
AU559192B2 (en)	1987-02-26
ZA837484B (en)	1984-06-27
DK464483A (da)	1984-04-09
JPS5989630A (ja)	1984-05-23
DK161564C (da)	1992-01-06
IL69938A (en)	1987-09-16
DE3380166D1 (en)	1989-08-17
IT8249241A0 (it)	1982-10-08
ATE44467T1 (de)	1989-07-15
EP0106812A3 (en)	1985-09-11
EP0106812A2 (en)	1984-04-25
US4568543A (en)	1986-02-04

Similar Documents

Publication	Publication Date	Title
MY101791A (en)	1992-01-31	New benzimidazole derivatives
ATE22562T1 (de)	1986-10-15	6-substituierte s-triazolo(3,4-a)phthalazinderivate.
ES8206180A1 (es)	1982-06-01	Un metodo para producir una composicion farmaceutica solida de un medicamento en microdosis.
LV5503A3 (lv)	1994-03-10	Panemiens omeprazola salu iegusanai
MY8700761A (en)	1987-12-31	Novel antihistamines process for their preparation and pharmaceutical compositions containing them
DE3271990D1 (en)	1986-08-21	Therapeutically active compound and pharmaceutical composition containing the same
EG18379A (en)	1992-11-30	Novel pharmacological compounds
DE69034226D1 (de)	2006-08-03	Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
MY108146A (en)	1996-08-30	Medicaments for treating inflammatory conditions or for analgesia
DK464483D0 (da)	1983-10-07	Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
ES8406439A1 (es)	1984-08-16	Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES8707488A1 (es)	1985-12-01	Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
FR2580649B1 (fr)	1991-03-29	(-) - 1b - ethyl - 1a - hydroxymethyl -1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine, procede pour la preparer et compositions pharmaceutiques contenant celle-ci
ATE87482T1 (de)	1993-04-15	Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
JPS53127832A (en)	1978-11-08	Antiphkogistics for oral administration containing thiaprostaglandins
DE3484155D1 (de)	1991-04-04	Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
ZA775472B (en)	1978-07-26	Biologically active tetracyclic compounds and pharmaceutical compositions containing same
ES8304059A1 (es)	1983-02-16	Procedimiento para la preparacion de composiciones a base desalicilato de imidazol
TR22867A (tr)	1988-09-19	Birden fazla aktif bilesen ihtiva eden insektisid terkibi
IT1178218B (it)	1987-09-09	Composti derivati dal fluorene ad attivita' antinfiammatoria, analgesica ed antipiretica e composizioni farmaceutiche che li contengono
ZA81615B (en)	1982-03-31	Cytostatically active pharmaceutical preparations and the use of poly-glycidyl-substituted n-heterocyclic ring compounds in pharmaceutical preparations
JPS52130926A (en)	1977-11-02	Medicinal composition comprising pentazocine and salicylamide
IT8321358A0 (it)	1983-05-30	Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
SE8704049D0 (sv)	1987-10-16	Novel pharmacological compounds
ES8201133A1 (es)	1981-12-01	Un procedimiento para la produccion de 1-(1-metiletil)amino-3-(4-alquiltio)-1-naftalenil-oxi-2-propanol.

Legal Events

Date	Code	Title	Description
2003-10-27	PUP	Patent expired